JP2022526017A5 - - Google Patents
Info
- Publication number
- JP2022526017A5 JP2022526017A5 JP2021559826A JP2021559826A JP2022526017A5 JP 2022526017 A5 JP2022526017 A5 JP 2022526017A5 JP 2021559826 A JP2021559826 A JP 2021559826A JP 2021559826 A JP2021559826 A JP 2021559826A JP 2022526017 A5 JP2022526017 A5 JP 2022526017A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- appears
- independently
- following structure
- bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025002846A JP2025065129A (ja) | 2019-04-11 | 2025-01-08 | プログラム可能なポリマー薬 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832726P | 2019-04-11 | 2019-04-11 | |
| US62/832,726 | 2019-04-11 | ||
| US201962877151P | 2019-07-22 | 2019-07-22 | |
| US62/877,151 | 2019-07-22 | ||
| PCT/US2020/027755 WO2020210692A1 (en) | 2019-04-11 | 2020-04-10 | Programmable polymeric drugs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025002846A Division JP2025065129A (ja) | 2019-04-11 | 2025-01-08 | プログラム可能なポリマー薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526017A JP2022526017A (ja) | 2022-05-20 |
| JP2022526017A5 true JP2022526017A5 (https=) | 2023-04-18 |
| JP7618137B2 JP7618137B2 (ja) | 2025-01-21 |
Family
ID=70482850
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559826A Active JP7618137B2 (ja) | 2019-04-11 | 2020-04-10 | プログラム可能なポリマー薬 |
| JP2025002846A Pending JP2025065129A (ja) | 2019-04-11 | 2025-01-08 | プログラム可能なポリマー薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025002846A Pending JP2025065129A (ja) | 2019-04-11 | 2025-01-08 | プログラム可能なポリマー薬 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220168433A1 (https=) |
| EP (1) | EP3952917A1 (https=) |
| JP (2) | JP7618137B2 (https=) |
| KR (1) | KR20210152524A (https=) |
| CN (1) | CN113905766A (https=) |
| WO (1) | WO2020210692A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| US11827661B2 (en) | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| KR102646956B1 (ko) | 2015-02-26 | 2024-03-14 | 소니그룹주식회사 | 페닐에티닐나프탈렌 염료 및 이의 사용 방법 |
| CN107709470B (zh) | 2015-05-11 | 2021-01-29 | 索尼公司 | 超亮二聚或多聚染料 |
| CN109415574B (zh) | 2016-04-01 | 2021-05-28 | 索尼公司 | 具有刚性间隔基团的超亮二聚体或聚合物染料 |
| AU2017240154B2 (en) | 2016-04-01 | 2021-08-12 | Sony Group Corporation | Ultra bright dimeric or polymeric dyes |
| WO2017177065A2 (en) | 2016-04-06 | 2017-10-12 | Sony Corporation | Ultra bright dimeric or polymeric dyes with spacing linker groups |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| JP7312929B2 (ja) | 2016-07-29 | 2023-07-24 | ソニーグループ株式会社 | 超明色二量体またはポリマー色素およびその調製のための方法 |
| WO2019071153A1 (en) | 2017-10-05 | 2019-04-11 | Sony Corporation | PROGRAMMABLE DENDRITIC MEDICINES |
| KR20260011205A (ko) | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| CN111836645A (zh) | 2017-11-16 | 2020-10-27 | 索尼公司 | 可编程的聚合药物 |
| CN111565756A (zh) | 2018-01-12 | 2020-08-21 | 索尼公司 | 包含生物活性化合物的具有刚性间隔基团的聚合物 |
| EP3737417B1 (en) | 2018-01-12 | 2025-08-27 | Sony Group Corporation | Phosphoalkyl ribose polymers comprising biologically active compounds |
| US12539334B2 (en) | 2018-01-12 | 2026-02-03 | Sony Group Corporation | Phosphoalkyl polymers comprising biologically active agents |
| KR102742386B1 (ko) | 2018-03-19 | 2024-12-16 | 소니그룹주식회사 | 형광 신호 향상을 위한 2가 금속의 사용 |
| CN118480073A (zh) | 2018-03-21 | 2024-08-13 | 索尼公司 | 具有连接体基团的聚合串联染料 |
| JP7580689B2 (ja) | 2018-06-27 | 2024-11-12 | ソニーグループ株式会社 | デオキシリボースを含むリンカー基を有するポリマー色素 |
| KR20210032434A (ko) | 2018-07-13 | 2021-03-24 | 소니 주식회사 | 유기인산염 단위를 포함하는 백본을 갖는 중합체성 염료 |
| CN113905766A (zh) * | 2019-04-11 | 2022-01-07 | 索尼集团公司 | 可编程的聚合药物 |
| WO2021062176A2 (en) | 2019-09-26 | 2021-04-01 | Sony Corporation | Polymeric tandem dyes with linker groups |
| EP4038081A1 (en) | 2019-09-30 | 2022-08-10 | Sony Group Corporation | Nucleotide probes |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| EP4256078A1 (en) | 2020-12-07 | 2023-10-11 | Sony Group Corporation | Spacing linker group design for brightness enhancement in dimeric or polymeric dyes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9545447B2 (en) * | 2013-01-04 | 2017-01-17 | The Texas A&M University System | Polymer-drug systems |
| EP3019559A4 (en) | 2013-08-22 | 2017-04-05 | Sony Corporation | Water soluble fluorescent or colored dyes and methods for their use |
| US11827661B2 (en) | 2015-02-26 | 2023-11-28 | Sony Group Corporation | Water soluble fluorescent or colored dyes comprising conjugating groups |
| CN107709470B (zh) * | 2015-05-11 | 2021-01-29 | 索尼公司 | 超亮二聚或多聚染料 |
| EP3455300A1 (en) | 2016-05-11 | 2019-03-20 | Sony Corporation | Ultra bright dimeric or polymeric dyes |
| KR20260011205A (ko) * | 2017-10-05 | 2026-01-22 | 소니그룹주식회사 | 프로그램가능한 중합체성 약물 |
| CN113905766A (zh) * | 2019-04-11 | 2022-01-07 | 索尼集团公司 | 可编程的聚合药物 |
-
2020
- 2020-04-10 CN CN202080040307.8A patent/CN113905766A/zh active Pending
- 2020-04-10 WO PCT/US2020/027755 patent/WO2020210692A1/en not_active Ceased
- 2020-04-10 JP JP2021559826A patent/JP7618137B2/ja active Active
- 2020-04-10 KR KR1020217036844A patent/KR20210152524A/ko active Pending
- 2020-04-10 EP EP20723675.3A patent/EP3952917A1/en active Pending
- 2020-04-10 US US17/602,722 patent/US20220168433A1/en active Pending
-
2025
- 2025-01-08 JP JP2025002846A patent/JP2025065129A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526017A5 (https=) | ||
| JP2022526651A5 (https=) | ||
| JP2022526014A5 (https=) | ||
| JP7703727B2 (ja) | 抗ｈｅｒ２抗体－薬物コンジュゲート | |
| WO2020210689A1 (en) | Programmable polymeric drugs | |
| WO2020210692A1 (en) | Programmable polymeric drugs | |
| WO2020210694A1 (en) | Programmable polymeric drugs | |
| KR102495426B1 (ko) | 항her3 항체-약물 콘주게이트 | |
| AU2007315211B2 (en) | FGFR4 antibodies | |
| JP2023551355A (ja) | 抗腫瘍化合物並びにその調製方法及び使用 | |
| CN102892787B (zh) | 放射性金属标记抗钙粘素抗体 | |
| CA2467738A1 (en) | Antibodies against carboxic anhydrase ix (ca ix) tumor antigen | |
| JP2018161141A (ja) | ヘテロ多量体分子を作製するための方法 | |
| JP2024537069A5 (https=) | ||
| US20250009786A1 (en) | Automated synthesis of polymeric dual drugs | |
| JP2024536224A5 (https=) | ||
| JP2025514636A5 (https=) | ||
| EP4408477A1 (en) | Pyrrolobenzodiazepine conjugates for cancer treatment | |
| JP2024508886A (ja) | 抗体－オリゴヌクレオチドコンジュゲートを使用した標的化の増強 | |
| KR20230142530A (ko) | 항체-약물 접합체 및 이의 의학적 용도 | |
| CN118139891A (zh) | 抗体药物偶联物及其制备方法和医药用途 | |
| TW202517255A (zh) | 化合物、組合物及方法 | |
| WO2026057076A1 (zh) | 基于抗liv-1抗体-药物偶联物的耐药癌症的治疗 | |
| TW202504641A (zh) | 用於淋巴瘤之診斷及治療方法的巨噬細胞特徵 | |
| CN118159296A (zh) | 聚合型双药的自动合成 |